Abstract
This study's aim was to project the long-term clinical and economic outcomes of continuous subcutaneous insulin infusion (CSII) treatment compared to multiple daily injections (MDI) in type 1 diabetes patients in Denmark.
| Bidragets oversatte titel | [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes] |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 172 |
| Udgave nummer | 27 |
| Sider (fra-til) | 2020-5 |
| Antal sider | 6 |
| ISSN | 0041-5782 |
| Status | Udgivet - 5 jul. 2010 |
Emneord
- Adult
- Cohort Studies
- Cost-Benefit Analysis
- Diabetes Complications
- Diabetes Mellitus, Type 1
- Female
- Health Care Costs
- Hemoglobin A, Glycosylated
- Humans
- Hypoglycemic Agents
- Infusions, Subcutaneous
- Insulin
- Insulin Infusion Systems
- Life Expectancy
- Male
- Prognosis
- Quality-Adjusted Life Years
- Treatment Outcome